Hiroshi Soda Selected Research

Granulocyte Colony-Stimulating Factor (G-CSF)

9/2021

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Soda Research Topics

Disease

21	Neoplasms (Cancer) 09/2021 - 02/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 03/2003
14	Lung Neoplasms (Lung Cancer) 04/2020 - 08/2003
10	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 03/2003
6	Breast Neoplasms (Breast Cancer) 03/2008 - 08/2003
4	Febrile Neutropenia 09/2021 - 06/2008
4	Adenocarcinoma 01/2016 - 10/2005
3	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2020 - 02/2010
3	Adenocarcinoma of Lung 01/2016 - 11/2007
3	Neutropenia 09/2012 - 06/2008
3	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2007 - 07/2005
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2006 - 06/2002
2	Fibrosis (Cirrhosis) 04/2020 - 01/2008
2	Pneumonia (Pneumonitis) 04/2020 - 11/2017
2	Pleural Effusion (Pleural Effusions) 01/2020 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2006
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2017 - 06/2014
2	Fever (Fevers) 06/2014 - 05/2012
2	Human Influenza (Influenza) 01/2014 - 05/2012
2	Prostatic Neoplasms (Prostate Cancer) 03/2003 - 02/2002
1	Pulmonary Alveolar Proteinosis 04/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2020
1	Bronchiectasis 04/2020
1	Malignant Pleural Effusion 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Malignant Mesothelioma 01/2020
1	Pleurisy (Pleuritis) 01/2020
1	Hemorrhage 10/2019
1	Amyloid Plaque 10/2019
1	Immunoglobulin Light-chain Amyloidosis 10/2019
1	Plasma Cell Neoplasms 10/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Erythema 11/2017
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Vomiting 01/2015
1	Motion Sickness (Airsickness) 01/2015
1	Nausea 01/2015

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 04/2020 - 03/2003
11	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2005
10	Irinotecan (Camptosar)FDA LinkGeneric 11/2012 - 08/2003
9	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2003
8	Tyrosine Kinase InhibitorsIBA 01/2018 - 02/2005
8	Gefitinib (Iressa)FDA Link 02/2011 - 02/2005
7	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2007
6	NivolumabIBA 01/2019 - 11/2017
5	amrubicinIBA 01/2022 - 06/2009
5	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 12/2004
5	Messenger RNA (mRNA)IBA 10/2005 - 02/2002
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2006
4	Topoisomerase I InhibitorsIBA 11/2006 - 08/2003
3	Immune Checkpoint InhibitorsIBA 10/2018 - 01/2018
3	Vinorelbine (Navelbine)FDA LinkGeneric 09/2012 - 01/2008
3	Adenosine Triphosphate (ATP)IBA 09/2005 - 08/2003
3	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2005 - 08/2003
3	Histone Deacetylase InhibitorsIBA 11/2004 - 02/2002
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 11/2006
2	LigandsIBA 01/2018 - 10/2006
2	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 07/2004
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015 - 06/2008
2	SteroidsIBA 01/2014 - 01/2005
2	Gemcitabine FDA Link 01/2011 - 05/2007
2	AntigensIBA 07/2009 - 01/2005
2	Biological ProductsIBA 07/2009 - 01/2007
2	MucinsIBA 10/2005 - 07/2005
2	Complementary DNA (cDNA)IBA 02/2005 - 01/2004
2	romidepsin (FK228)FDA Link 11/2004 - 03/2003
2	CamptothecinIBA 07/2004 - 01/2004
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2004 - 08/2003
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2003 - 01/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2003 - 02/2002
2	Histone Deacetylases (Histone Deacetylase)IBA 03/2003 - 02/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2021
1	Azacitidine (5 Azacytidine)FDA Link 04/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	RamucirumabIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	VildagliptinIBA 01/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 10/2019
1	Amyloid (Amyloid Fibrils)IBA 10/2019
1	nedaplatinIBA 01/2019
1	AfatinibIBA 01/2018
1	Circulating Tumor DNAIBA 01/2018
1	osimertinibIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Pemetrexed (MTA)FDA Link 11/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Anaplastic Lymphoma KinaseIBA 01/2016
1	Palonosetron (Aloxi)FDA Link 01/2015
1	AntiemeticsIBA 01/2015
1	Aprepitant (Emend)FDA Link 01/2015
1	PowdersIBA 06/2014

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 09/2021 - 03/2003
6	Therapeutics 01/2020 - 01/2007
5	Radiotherapy 01/2022 - 08/2007
1	Traction 04/2020
1	Chemoradiotherapy 11/2017
1	Catheters 01/2017
1	Salvage Therapy 01/2015